Subscribe free

Intestine and Lower Gastrointestinal Tract ·

Significant improvement in survival rates for colon cancer patients

A comprehensive evaluation of non-metastatic colon cancer outcomes revealed a nearly 10% increase in overall and cancer-specific survival rates over the last two decades. The analysis, encompassing over 195,000 patients, highlighted demographic disparities, particularly in proximal cancer cases, which were more prevalent among older, female patients. Improved survival rates were consistent across all colon segments and stages, indicating advancements in treatment and awareness of colon cancer management.

Journal Article by Benlice C, Elhan AH (…) Kuzu MA et 2 al. in Tech Coloproctol

© 2024. Springer Nature Switzerland AG.

read the whole article in Tech Coloproctol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

All papers in Intestine and Lower Gastrointestinal Tract →